NCT06603220Phase 2Completed

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2025-05-08Actual

Enrollment · participants30Actual

Source updated2026-05-19Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-16 · 1 field changed

Primary outcomes · main study measures

Text edit · unverified significance

− Previous value

measure: Safety and tolerability

+ Updated value

measure: Safety and Tolerability

The saved outcome text may be shortened. Check the source for full wording.

Check registry source